Royal Philips has signed a $646.7 million deal with the U.S. Department of Health and Human Services to produce 2,500 ventilators for the strategic national stockpile by May 31 and a total of 43,000 ventilators by Dec. 31.

To do this, company officials said Thursday they intend to double production of ventilators at the Philips Respironics facility in Murrysville and also at a second facility in Carlsbad, Calif.

“There is an unprecedented global demand for medical equipment to help diagnose and treat patients with COVID-19,” said CEO Frans van Houten in a release. “We welcome the support of the U.S. government in our efforts to aggressively increase the production of hospital ventilators.”

HHS officials said five additional ventilator companies will receive contracts “in the coming week.”

Advertise with us

Philips Respironics earlier posted job openings for production line workers at the Murrysville plant to allow for around-the-clock shifts assembling and testing ventilators to shore up a dwindling inventory of the life-saving breathing machines.

A spokeswoman said the company “is closely working with its suppliers in the U.S., Europe and Asia for an uninterrupted flow” of the more than 650 components parts in each ventilator.

Under the Defense Production Act, U.S. suppliers are required to give priority to Royal Philips and the five other ventilator makers — General Electric, Hill-Rom, Medtronic, ResMed and Vyaire Medical — for deliveries. In addition, a Royal Philips spokesman said if a supplier is in a lockdown region “then the DPA will allow it to stay open, and continue the deliveries.”

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.

Updated at 1:22 p.m. on April 9, 2020

Advertise with us

This story was originally published with images that are no longer available.